UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
−Removed: There were no unregistered sales of equity securities during the nine months ended June 30, 2024.
−Removed: In addition, there were no shares of Common Stock purchased by us during the nine months ended June 30,
+Added: There were no unregistered sales of equity securities during the three months ended December 31, 2024.
+Added: In addition, there were no shares of Common
+Added: Stock purchased by us during the three months ended December 31, 2024.
EXHIBIT INDEX
−Removed: Consent, Joinder and Seventh Amendment to Amended and Restated Loan and Security Agreement, dated as of June 5, 2024, by and among Santander Bank, N.A., as lender, Janel Group, Inc., Expedited
−Removed: Logistics and Freight Services, LLC, ELFS Brokerage LLC, Janel Corporation, Expedited Logistics and Freight Services, LLC and Airschott, Inc.
−Removed: (filed herewith)
+Added: Eighth Amendment to Amended and Restated Loan and Security Agreement,
+Added: dated November 1, 2024, by and among Santander Bank, N.A., as lender,
+Added: Janel Group, Inc., Expedited Logistics
+Added: and Freight Services, LLC, ELFS Brokerage LLC, and
+Added: Airschott, Inc., as borrower, Janel Corporation, Expedited Logistics and
+Added: Freight Services, LLC, as obligors (filed herewith).
+Added: Second Amendment to Amended and Restated Acquisition Note, dated November 22, 2024, by and among Indco, Inc., Antibodies
+Added: Incorporated, Aves Labs, Inc., PhosphoSolutions LLC, Immunochemistry Technologies
+Added: LLC, ECM Biosciences, LLC, ImmunoBioScience Corp, and ViraQuest, Inc., as borrowers,
+Added: hereby jointly and severally promise to pay to the order of First Merchants as Lender
+Added: Second Amendment to Amended and Restated Revolving Note dated November 22, 2024, by and among Indco, Inc.,
+Added: Antibodies Incorporated, Aves Labs, Inc., PhosphoSolutions LLC, Immunochemistry
+Added: Technologies LLC, ECM Biosciences, LLC, ImmunoBioScience Corp, and ViraQuest,
+Added: Inc., as borrowers, hereby jointly and severally promise to pay to the order of
+Added: First Merchants as Lender (filed herewith).
+Added: Second Amendment to Amended and Restated Term A Note dated November 22, 2024, by and among Indco, Inc.,
+Added: Antibodies Incorporated, Aves Labs, Inc., PhosphoSolutions LLC, Immunochemistry
+Added: Technologies LLC, ECM Biosciences, LLC, ImmunoBioScience Corp, and ViraQuest,
+Added: Inc., as borrowers, hereby jointly and severally promise to pay to the order of
+Added: First Merchants as Lender (filed herewith).
+Added: Second Amendment to Amended and Restated Term B Note dated November 22, 2024, by and among Indco, Inc.,
+Added: Antibodies Incorporated, Aves Labs, Inc., PhosphoSolutions LLC, Immunochemistry
+Added: Technologies LLC, ECM Biosciences, LLC, ImmunoBioScience Corp, and ViraQuest,
+Added: Inc., as borrowers, hereby jointly and severally promise to pay to the order of
+Added: First Merchants as Lender (filed herewith).
Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer (filed herewith).
−Removed: Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer (filed herewith)
−Removed: Section 1350 Certification of Principal Executive Officer (filed herewith)
−Removed: Section 1350 Certification of Chief Financial Officer (filed herewith)
−Removed: Interactive data files providing financial information from the Company’s Quarterly Report on Form 10-Q for the three and nine months ended June 30, 2024 and 2023 in Inline
−Removed: XBRL (eXtensible Business Reporting Language) pursuant to Rule 405 of Regulation S-T:
−Removed: (i) Condensed Consolidated Balance Sheets as of June 30, 2024 and September 30, 2023, (ii) Condensed Consolidated Statements of Operations for the three and
−Removed: nine months ended June 30, 2024 and 2023, (iii) Condensed Consolidated Statement of Changes in Stockholders’ Equity for the three and nine months June 30, 2024 and 2023, (iv) Condensed Consolidated Statements of Cash Flows for the nine months
−Removed: ended June 30, 2024 and 2023, and (v) Notes to Condensed Consolidated Financial Statements.
−Removed: Cover Page Interactive Data File (formatted as Inline XBRL and contained in the Interactive Data Files submitted as Exhibit 101) (filed herewith)
−Removed: Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
−Removed: August 2, 2024
+Added: Rule 13a-14(a)/15d-14(a) Certification of Principal Chief Financial Officer (filed herewith).
+Added: Section 1350 Certification of Principal Executive Officer (filed
+Added: Section 1350 Certification of Principal Chief Financial Officer (filed
+Added: Interactive data files providing financial information from the
+Added: Company’s Quarterly Report on Form 10-Q for the three
+Added: months ended December 31, 2024 and 2023 in Inline XBRL (eXtensible
+Added: Business Reporting Language) pursuant to
+Added: Rule 405 of Regulation S-T:
+Added: (i) Condensed Consolidated
+Added: Balance Sheets as of December 31, 2024 and September 30, 2024, (ii)
+Added: Condensed Consolidated Statements of Operations for the three months
+Added: ended December 31, 2024 and 2023, (iii) Condensed
+Added: Consolidated Statement of Changes in Stockholders’
+Added: Equity for the three months December 31, 2024 and 2023,
+Added: (iv) Condensed Consolidated Statements of Cash Flows for the three
+Added: months ended December 31, 2024 and 2023, and (v) Notes to Condensed
+Added: Consolidated Financial Statements.
+Added: Cover Page Interactive Data File (formatted as Inline XBRL and contained
+Added: in the Interactive Data Files submitted as Exhibit 101) (filed herewith).
+Added: Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the
+Added: undersigned thereunto duly authorized.
+Added: February 7, 2025
JANEL CORPORATION
2 unchanged sentences
( Principal Executive Officer)
−Removed: August 2, 2024
−Removed: JANEL CORPORATION
+Added: February 7, 2025
/s/ Joseph R.
Chief Financial Officer, Treasurer and Secretary
+Added: (Principal Financial Officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.